Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995980 · ClinicalTrials.gov registry record · NA
Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT02995980 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 128 participants.
The verdict
NCT02995980, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer.
Interventions
- DEVICE Dual-Energy Contrast-Enhanced (DECE) mammography
- DEVICE digital mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02995980
The ClinicalTrials.gov registry entry for NCT02995980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dual-Energy Contrast-Enhanced (DECE) mammography is the first listed.
NCT02995980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02995980 about?
NCT02995980 is a clinical study titled "Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography". This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enha...
What is the current status of trial NCT02995980?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2015-11. Estimated completion is 2018-05-31.
What interventions are being tested in trial NCT02995980?
The interventions under investigation include: Dual-Energy Contrast-Enhanced (DECE) mammography (DEVICE), digital mammography (DEVICE).
Who is sponsoring clinical trial NCT02995980?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.